Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY-TT primary vaccination study in healthy children aged 1-10 years
2006-004236-70Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2006
- Modality
- Vaccines & Immunotherapeutics, Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in meningococcal disease comparing MenACWY-TT, Mencevax ACWY control and Meningitec control (3 arms). Started Nov 2006; status: completed.
02
Drugs
meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccinemeningococcal ACYW135 vaccineMeningococcal group C polysaccharide conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2006-004236-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004236-70.